Abstract
Diabetes mellitus, a chronic metabolic disease with an alarming global prevalence, is associated with several serious health threats, including cardiovascular diseases. Current diabetes treatments have several limitations and disadvantages, creating the need for new effective formulations to combat this disease and its associated complications. This motivated the development of therapeutic strategies to overcome some of these limitations, such as low therapeutic drug bioavailability or poor compliance of patients with current therapeutic methodologies. Taking advantage of silica nanoparticle characteristics such as tuneable particle and pore size, surface chemistry and biocompatibility, silica-based nanocarriers have been developed with the potential to treat diabetes and regulate blood glucose concentration. This review discusses the main topics in the field, such as oral administration of insulin, glucose-responsive devices and innovative administration routes.
Funder
FCT/MCTES
FCT-Fundação para a Ciência e Tecnologia, I.P.
Reference129 articles.
1. World Health Organization (2016). Global Report on Diabetes, World Health Organization.
2. World Health Organization (2016). Diabetes Portugal 2016 Country Profile, World Health Organization.
3. Lipid nanoparticles for mRNA delivery;Hou;Nat. Rev. Mater.,2021
4. Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions;Han;Nat. Nanotechnol.,2020
5. Long-term oral administration of Exendin-4 to control type 2 diabetes in a rat model;Suzuki;J. Control. Release,2019
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献